{
    "code": "52026252",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52026252",
    "time": "2020-10-23 10:32:22",
    "許可證字號": "衛部藥輸字第026252號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "113\/02\/19",
    "發證日期": "103\/02\/19",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA05202625203",
    "中文品名": "適克通膜衣錠75毫克",
    "英文品名": "NOKLOT 75 (CLOPIDOGREL TABLETS USP 75MG)",
    "適應症": "Clopidogrel適用於粥狀動脈栓塞事件的次級預防於下列病人：\r\n降低近期發生中風、心肌梗塞或周邊動脈血管疾病的粥狀動脈硬化病人之粥狀動脈栓塞事件(如：心肌梗塞、中風或其他因血管病變引起的死亡)的發生。與ASPIRIN併用降低非ST段上升之急性冠心症(不穩定性心絞痛和非Q波型心肌梗塞)病人(包括經皮冠狀動脈介入性治療後放置支架的患者)之粥狀動脈栓塞事件。與ASPIRIN併用可用於以內科治療的ST段上升之急性心肌梗塞病人。不適合接受Vitamin K antagonists的心房纖維顫動病人，併有至少一個發生血管事件危險因子，且屬於出血危險性低者，可與aspirin併用以預防粥狀動脈栓塞及血栓栓塞事件，包括中風。",
    "劑型": "116膜衣錠",
    "包裝": "2-1000錠鋁箔盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "CLOPIDOGREL HYDROGEN SULPHATE",
    "限制項目": "02輸　入 24監視期滿學名藥",
    "申請商名稱": "640102B347  毅有生技醫藥股份有限公司",
    "申請商地址": "臺北市信義區基隆路2段137號3樓",
    "主製造廠": [
        {
            "製造廠名稱": "FIN0132000  CADILA HEALTHCARE LIMITED",
            "製造廠廠址": "Plot No. 417, 419, 420, Sarkhej-Bavla N.H. No. 8A, Village-Moraiya, Tal-Sanand, Dist: Ahmedabad-382 210, India.",
            "製造廠公司地址": "",
            "製造廠國別": "INDIA",
            "製程": ""
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2012600220",
            "成分名稱": "CLOPIDOGREL HYDROGEN SULPHATE",
            "含量描述": "Clopidogrel Bisulphate (equivalent to 75 mg of Clopidogrel)",
            "含量": "97.8750000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "NOKLOT 75 - PI - Taiwan -20200804_final-109-08-06.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026252&Seq=007&Type=9"
        },
        {
            "title": "NOKLOT 75 - F - Taiwan_20190214_Final (TFDA)-108-02-15.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026252&Seq=002&Type=8"
        },
        {
            "title": "NOKLOT 75 - C - Taiwan -20190214_Final(TFDA)-108-02-15.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026252&Seq=001&Type=8"
        }
    ]
}